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Renée van AmerongenAbstract
For many decades, developmental biologists and
cancer researchers alike have been trying to understand
the relationship between the basal and luminal cell
compartments in the mouse mammary epithelium.
Delineating the mammary stem and progenitor cell
hierarchy will provide fundamental knowledge of how
cell proliferation and differentiation are orchestrated to
build, maintain and regenerate a complex mammalian
tissue. Moreover, it is expected to offer insight into
the cells of origin for human breast cancer. A new
lineage-tracing study has fuelled the discussion as to
the existence of bipotent stem cells in the basal layer of
the mouse mammary epithelium.The resulting ternary system allows them to induce sto-Background
Despite its simple appearance, the bilayered mammary
epithelium contains multiple cell populations that dis-
play complex and dynamic behaviors during different
stages of development. The large proliferative and regen-
erative potential stored in the mouse mammary epithe-
lium is assigned to one or more populations of stem and
progenitor cells. These can be prospectively isolated by
fluorescence-activated cell sorting from the basal and lu-
minal cell fractions, respectively [1-3]. They are conse-
quently distinguished by functional assays [4,5]: while
limiting numbers of stem cells have the capacity to gen-
erate a complete ductal network upon transplantation
into the cleared fat pad, progenitors show the propensity
to form colonies in primary in vitro cultures.
A long-lived, bipotent stem cell is thought to lie at the
base of the mammary epithelial cell hierarchy [6]. However,
this model has been challenged by in situ lineage-tracing
analyses, one of which demonstrated that transplantation
can unlock a multi-lineage potential that is not used during
normal development [7] and another that questioned the
existence of bipotent stem cells altogether by showing that
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A recent lineage-tracing study by Rios and colleagues [9]
adds new fuel to the fire by demonstrating the existence of
bipotent stem cells in the basal layer of the adult mammary
epithelium. And so the discussion is reignited: are mam-
mary stem cells bipotent or not? And what is the reason
for this controversy in the first place?Multicolor lineage tracing
Rios and colleagues use state-of-the-art lineage tracing
technology to track the developmental fate of a luminal
(Elf5+) and a basal (K5+) cell population. For this pur-
pose, they develop two novel mouse lines (Elf5-rtTA-
IRES-GFP and K5-rtTA-IRES-GFP), which they combine
with a tetO-Cre and a Rosa26Confetti reporter allele [10].
chastic recombination of the multicolor reporter by ad-
ministering a single dose of doxycycline, resulting in the
stable expression of cyan fluorescent protein (CFP), green
fluorescent protein (GFP), yellow fluorescent protein
(YFP) or red fluorescent protein (RFP). By combining
their multicolor tracing approach with a high-resolution,
wholemount three-dimensional imaging protocol, the au-
thors can beautifully visualize (and discriminate) adjacent
myoepithelial (that is, basal) and luminal cells.
Luminal Elf5+ cells could be labeled in both the puber-
tal and the adult epithelium, where they contributed to
the expansion and maintenance of the ductal epithelial
network. However, labeled clones did not expand in size
and were lost after a 12-week trace in adulthood, indi-
cating that Elf5 marks a luminal progenitor cell popula-
tion. In contrast, K5+ cells in the basal layer of the
epithelium gave rise to clonal patches comprising basal
as well as luminal cells. Both in the pubertal and in the
adult gland, these clones were long lived and showed ex-
pansive growth, giving rise to unicolored patches of
ductal epithelium.Conceptual advances and missed opportunities
Compared to other reporter alleles in which recombined
cells are marked by a single color, the multicolor labeling
strategy used by Rios and colleagues greatly enhancestral Ltd. The licensee has exclusive rights to distribute this article, in any
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scored as being clonally related. However, even with a
multicolor reporter it is important to achieve low levels
of recombination, particularly when it comes down to
quantitative analyses (that is, clone size or the number
of myoepithelial versus luminal cells belonging to a
single clone). In fact, one could argue that the substan-
tial labeling achieved with a single pulse of Cre activity
(up to 30% of the epithelium is labeled after 2 days)
somewhat obscures the unequivocal interpretation of
the experimental data. In this respect, future studies
would benefit from performing ‘re-tracing’ [11] to demon-
strate the de novo appearance of a mixed-lineage clone
from K5+ cells within an already existing clone.
Importantly, however, the detection of tethered myoe-
pithelial and luminal cells within the same (that is, uni-
colored) clone further strengthens the argument that
they are derived from a common precursor. In this re-
spect, it is a pity that the authors do not fully exploit
their wholemount three-dimensional imaging protocol
by showing movies of three-dimensional reconstructed
mixed myoepithelial/luminal cell clones. They also fail
to take full advantage of the presence of an IRES-GFP
marker in their transgenic driver lines. GFP detection
would have been especially informative in mixed clones
as further support for asymmetric cell division. GFP
expression analysis in short, 2-day trace experiments
would also have been useful to demonstrate that the
initial recombination event indeed occurred in only
the basal or luminal cell fraction of interest, as one in-
herent limitation of the lineage tracing technology
using fluorescent reporter alleles is that the earliest
signs of recombination in the mammary gland can often
only be detected 48 hours after tamoxifen or doxycycline
administration.
Future challenges
Although the findings of Rios and colleagues confirm
the previously reported existence of bipotent adult stem
cells in the basal layer [7], the question is how these tra-
cing data, particularly those initiated from K5+ cells,
should be viewed in light of the previous study by Van
Keymeulen and colleagues [8], which clearly demon-
strated lineage restriction for K5+ and K14+ cells. One
explanation could be the use of extremely high doses of
tamoxifen (15 mg administered during puberty) by Van
Keymeulen and colleagues. According to Rios and col-
leagues, far lower doses of tamoxifen already inhibit out-
growth of the ductal epithelium during puberty [9],
which is something that we have observed as well. It is
conceivable that the bipotent stem cells are affected by
high concentrations of tamoxifen, causing them to die
(as previously observed for the +4 cells in the intestinal
crypt [12]) or to restrict their lineage potential. In thisrespect, using the rtTA/tetO-Cre/doxycycline system
would be preferential to using a CreERT2/tamoxifen-
mediated approach. However, this will generally not be
compatible with many existing mouse strains and also
requires more complex and expensive breeding strat-
egies. On the bright side, using lower concentrations
of tamoxifen appears to have only minor, transient ef-
fects on the mammary epithelium [13] and, as demon-
strated previously for Axin2CreERT2 [7] as well as for
K5CreERT2 and K14CreERT2 by Rios and colleagues, this
system in itself is compatible with tracing bipotent
stem cells.
A second explanation lies in the use of different mouse
strains. Despite their often deceptively similar names,
their identity and origin can be very different. For in-
stance, between the two of them, Rios and colleagues
and Van Keymeulen and colleagues use three different
strains to mark the K5+ basal cell population. One is a
CreERT2 knock-in in the 3′ UTR of the endogenous K5
locus generated by the Blanpain lab [8], the second is a
K5CreERT2 transgenic line containing the human K5 pro-
moter generated by the Hogan lab [14] and the third is
the K5-rtTA-IRES-GFP transgenic line developed by Rios
and colleagues, which contains a bovine K5 promoter
[9]. The same holds for the K14-rtTA and K14-CreERT2
lines used in these studies, with origins in the Fuchs [8]
and Chambon labs [9]. Although all of these lines mark
basal cell populations, subtle (or not so subtle) differ-
ences in their expression levels or activity pattern are to
be expected. The only way forward is for investigators to
be aware of these differences and to properly document
and report them.
Finally, unlike the intestine, which is composed of dis-
tinct crypt/villus structures in which cells move along a
fixed trajectory, the mammary epithelium lacks a stable
architectural unit. This complicates both the analysis
and interpretation of in situ lineage-tracing experiments.
As we grapple to gain experimental control over this
technology, it becomes apparent that we still need to
gain a far better understanding of many of the basic
properties of the tissue, including the steady state turn-
over of the basal and luminal compartments, the differ-
ences between growth and maintenance of the pubertal
and the adult epithelium as well as between the ductal
and lobuloalveolar portions of the gland and the cellular
complexity of both the basal and the luminal layer. It
will probably take a lot more tracing before we can con-
nect the dots.
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